CA50971-2A - 0x0000000000006F73
Males & Females of Non-Childbearing Potential
Badger
* Stipend may pay up to reflected amount.
Start Date:
September 15, 2026 - 1:30pm
End Date:
October 15, 2026 - 11:00am
Study Details
Study Number: CA50971
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,750.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32.44
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed to treat Alzheimer's Disease.
Route of Administration: Oral
Blood Draws: 21
Study Schedule
Schedule Type: Long Term
Study Length: 10 Night Stay & 2 Phone Calls
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 9/3/2026 |
| Wednesday | 9/9/2026 |
| Friday | 9/11/2026 |
| Monday | 9/14/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 9/3/2026 |
| Wednesday | 9/9/2026 |
| Friday | 9/11/2026 |
| Monday | 9/14/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 9/15/2026 1:30:00 PM | Friday | 9/25/2026 8:00:00 AM | 1 | Lincoln |
| Phone participant | Thursday | 10/1/2026 11:00:00 AM | 1 | Lincoln | ||
| Phone participant | Thursday | 10/15/2026 11:00:00 AM | 1 | Lincoln |
